New hope for tough breast cancer: targeted drug trial opens
NCT ID NCT06908928
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This early-phase trial tests a new drug called bulumtatug furvedotin (BFv) in people with triple-negative breast cancer that has returned or spread and who have already tried certain other treatments. The study aims to see if BFv can shrink tumors or stop them from growing. About 52 participants will receive the drug, and researchers will monitor how well it works and any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRIPLE NEGATIVE BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Anschutz Medical Center
RECRUITINGAurora, Colorado, 80045, United States
-
City of Hope
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-••••
Contact
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10021, United States
Contact Phone: •••-•••-••••
Contact
-
UCSD Moores Cancer Center
RECRUITINGLa Jolla, California, 92093, United States
Contact Phone: •••-•••-••••
Contact
-
UChicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.